日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

In silico evidence of monkeypox F14 as a ligand for the human TLR1/2 dimer

计算机模拟证据表明，猴痘病毒F14是人TLR1/2二聚体的配体。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1544443
Chakraborty, Ankita; Das, Nabarun Chandra; Gupta, Parth Sarthi Sen; Panda, Saroj Kumar; Rana, Malay Kumar; Bonam, Srinivasa Reddy; Bayry, Jagadeesh; Mukherjee, Suprabhat
微生物学
猴痘
发表日期：2025
文献求助 收藏

Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings

程序性细胞死亡通路作为开发抗丝虫药物的靶点：来自近期研究的启示

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.2
doi:10.1111/jcmm.17913
Das, Nabarun Chandra; Chakraborty, Pritha; Nandy, Samapika; Dey, Abhijit; Malik, Tabarak; Mukherjee, Suprabhat
信号转导
细胞生物学
发表日期：2023
文献求助 收藏

Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation.

人类单克隆抗体对 SARS-CoV-2 Omicron 变异株的结合能力比较：计算机模拟研究

期刊:Antibodies
影响因子:2.7
doi:10.3390/antib12010017
Das Nabarun Chandra, Chakraborty Pritha, Bayry Jagadeesh, Mukherjee Suprabhat
炎症/感染
新冠
Human
发表日期：2023
文献求助 收藏

In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein

利用计算机模拟分析比较治疗性人源单克隆抗体对抗携带突变刺突蛋白的新型SARS-CoV-2变种病毒的潜在疗效

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.782506
Das, Nabarun Chandra; Chakraborty, Pritha; Bayry, Jagadeesh; Mukherjee, Suprabhat
单克隆抗体
Human
SARS-CoV-2
微生物学
发表日期：2021
文献求助 收藏

Exploring the Differential Expression and Prognostic Significance of the COL11A1 Gene in Human Colorectal Carcinoma: An Integrated Bioinformatics Approach

探索COL11A1基因在人类结直肠癌中的差异表达及其预后意义：一种整合生物信息学方法

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2021.608313
Patra, Ritwik; Das, Nabarun Chandra; Mukherjee, Suprabhat
肿瘤
肠癌
肿瘤免疫
Human
COL
发表日期：2021
文献求助 收藏